HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tamalee Scott Selected Research

Neoplasms (Cancer)

9/2011Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102.
8/2006Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts.
6/2005Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions.
4/2005Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid.
9/2004Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation.
4/2004In vivo tumor imaging in mice with near-infrared labeled endostatin.
2/2004In vivo tumor imaging using a near-infrared-labeled endostatin molecule.
6/2003Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tamalee Scott Research Topics

Disease

8Neoplasms (Cancer)
09/2011 - 06/2003
3Glioma (Gliomas)
09/2011 - 09/2003
1Glioblastoma (Glioblastoma Multiforme)
09/2011
1Ovarian Neoplasms (Ovarian Cancer)
08/2006
1Mesothelioma
08/2006
1Epilepsy (Aura)
04/2005
1Brain Neoplasms (Brain Tumor)
04/2005
1Carcinoma (Carcinomatosis)
09/2004
1Lewis Lung Carcinoma
04/2004

Drug/Important Bio-Agent (IBA)

2DNA (Deoxyribonucleic Acid)IBA
09/2011 - 04/2005
2Histone Deacetylases (Histone Deacetylase)IBA
04/2005 - 09/2004
2Coloring Agents (Dyes)IBA
04/2004 - 02/2004
2EndostatinsIBA
04/2004 - 02/2004
2CY5.5 cyanine dyeIBA
04/2004 - 02/2004
1Neutralizing AntibodiesIBA
09/2011
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
09/2011
1Monoclonal AntibodiesIBA
09/2011
1rilotumumabIBA
09/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2006
1MesothelinIBA
08/2006
1Immunotoxins (Immunotoxin)IBA
08/2006
1ChromatinIBA
04/2005
1Valproic Acid (Depakote)FDA LinkGeneric
04/2005
1Pharmaceutical PreparationsIBA
04/2005
1Chelating AgentsIBA
10/2004
1PolyaminesIBA
10/2004
1Trientine (Trien)FDA Link
10/2004
1entinostat (MS 275)IBA
09/2004
1Histones (Histone)IBA
09/2004
1Indicators and Reagents (Reagents)IBA
09/2004
1Histone Deacetylase InhibitorsIBA
09/2004
1Platelet Endothelial Cell Adhesion Molecule-1IBA
04/2004
1oxophenylarsine (phenylarsine oxide)IBA
02/2004
1Green Fluorescent ProteinsIBA
02/2004
1tachpyrIBA
09/2003
1Biological ProductsIBA
06/2003

Therapy/Procedure

2Therapeutics
06/2005 - 09/2004
1Injections
09/2004
1Intraperitoneal Injections
02/2004
1Radiotherapy
06/2003
1Immunotherapy
06/2003